What are the Fitzpatrick skin phototypes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fitzpatrick Skin Phototypes

The Fitzpatrick skin phototype classification system categorizes skin into six types (I through VI) based on the skin's response to ultraviolet radiation exposure, specifically the tendency to sunburn versus the ability to tan. 1

The Six Fitzpatrick Skin Types

The classification system divides skin into the following categories based on UV response 2:

  • Type I: Always burns, never tans
  • Type II: Usually burns, tans minimally
  • Type III: Sometimes burns, tans gradually to light brown
  • Type IV: Burns minimally, tans well to moderate brown
  • Type V: Rarely burns, tans deeply to dark brown
  • Type VI: Never burns, deeply pigmented (dark brown to black)

Clinical Applications

Phototherapy Dosing

The Fitzpatrick classification is used to estimate initial therapeutic doses of UV light in clinical practice 1. Specific phototherapy responses vary by skin type:

  • Types III-VI demonstrate significant delayed tanning responses during PUVA therapy 2
  • Types IV-VI are more prone to developing nail pigmentation changes (photo-onycholysis and longitudinal melanonychia) during phototherapy 2

Risk Assessment

The classification helps predict 1:

  • Risk of photodamage and skin cancer
  • Outcomes of aesthetic procedures
  • Need for sun protection measures

Important Limitations and Caveats

Accuracy Issues in Self-Reporting

Self-reported Fitzpatrick skin type is significantly less accurate than dermatologist-determined classification, particularly for types III through VI. 3

  • In ethnically diverse populations, 42% of participants' responses to burning and tanning questions could not be classified using standard FST definitions 3
  • Self-report failed to distinguish between types IV and V when validated against objective spectrophotometry measurements 3
  • Dermatologist-determined FST showed statistically significant differences between types III-IV and IV-V, while participant-determined FST did not differentiate IV from V 3

Poor Predictive Value in Diverse Populations

Race and pigmentary phenotypes are weak predictors of actual Fitzpatrick type 4:

  • A multivariate model using race, sex, skin color, eye color, and hair color only predicted FST to within 1 point with 92% accuracy (weighted kappa 0.53) 4
  • For Black/Black Hispanic participants, only 5% of variance in FST was accounted for by objective skin color measurements, compared to 30% for White/White Hispanic participants 5
  • The classification provides a restricted range of options for people with darker skin that does not capture variations in their skin color 5

Questionable Validity in Non-White Populations

In Korean brown skin, the relationship between self-reported Fitzpatrick type and minimal erythema dose (MED) was weak at best 6:

  • No significant difference in MEDs between types IV and V 6
  • Subjects with MEDs corresponding to type V were found across all categories, even types II and III 6
  • Mean MED did not show a monotonic increase with increasing skin type 6

Clinical Recommendation

When using Fitzpatrick classification for clinical assessment, dermatologist determination is essential rather than patient self-report, particularly for skin types III-VI. 3 For patients with darker skin, consider that the burning and tanning questions may need rephrasing using specific descriptors such as skin irritation, tenderness, itching, or skin becoming darker to improve accuracy 3. Objective measurement techniques like reflectance spectrophotometry may be necessary when precise classification is critical for treatment planning or cancer risk assessment 3, 5.

Related Questions

In a 23‑year‑old woman with dysuria, burning and tearing sensation during and after intercourse, should she be referred to a gynecologist first or a urologist?
What is the most appropriate initial evaluation and management for a 26‑year‑old woman with a 2‑3‑week history of severe right‑breast pain radiating to the shoulder and neck, no palpable mass, skin changes, nipple discharge, or systemic symptoms, and a recent cessation of breastfeeding?
In a 15‑year‑old male with persistent left lower‑quadrant abdominal tenderness and bruising, right‑sided back pain radiating to the ribs, and new left great‑toe stabbing pain with tingling after a recent appendectomy, what imaging studies and medical management are indicated?
How should a 23-year-old male presenting with dysuria and urethral discharge be evaluated and treated?
Are Kegel exercises safe to perform during recovery from a fistulotomy?
What is the recommended dose, administration schedule, contraindications, and monitoring for sibeprenlimab in adults with primary IgA nephropathy and proteinuria who are already receiving maximally tolerated angiotensin‑converting enzyme inhibitor or angiotensin‑receptor blocker therapy (with or without a sodium‑glucose cotransporter‑2 inhibitor)?
In a child with nephrotic‑range proteinuria and severe hypoalbuminemia, is albumin infusion indicated for managing refractory edema?
What are the risk factors for basal cell carcinoma?
What central and peripheral neuromodulators are recommended for treating epigastric pain syndrome (EPS) and post‑prandial distress syndrome (PDS)?
What is the appropriate evaluation and management for a patient on anti‑tubercular therapy who develops new‑onset slurred speech?
Are there safety or interaction concerns with my sleep regimen of L‑tryptophan 1000 mg, L‑theanine 200 mg, lemborexant 5 mg, ibuprofen extended‑release 10 mg (twice daily) and pyridostigmine 60 mg for insomnia with frequent awakenings?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.